Nancy Dvorin

Managing Editor

20 Years of Experience

About

@NancyDvorin has been covering and analyzing the medical device and pharmaceutical industries for more than 20 years. Prior to joining MedTech Strategist, she was the managing editor of several life sciences business publications including In Vivo and Medtech Insight. Earlier in her career, Nancy managed library and information services for a number of multinational corporations.

Specialties
Publications
Articles from Nancy Dvorin:
Read all from this author
Regulatory & Reimbursement

Digital Edition: Market Pathways March 2025

  • 2025-03-01 00:00:00.0
  • Nancy Dvorin
  • Market Pathways

After eight years of industry clamor for MDR/IVDR reform, there are some signs of movement: MedTech Europe execs express cautious optimism that concrete changes may be in the offing; we review the EU MDCG's new guidance on structured dialogue for notified bodies and a draft EC regulation on electronic labeling. Also inside, implementing Phase 0 analysis before embarking on clinical modernization initiatives; whiplash at CDRH; and a graphic look at device approvals in China.

Read Article